Thats another one underway. "Awarded $372,654 in matched funding from competitive Biomedical Translation Bridge (BTB) program" means we are investing the same amount I assume. That again suggest BD1 is getting by on the smell of a oily rag and kicking goal after goal doing so.
Nice start to the day "clinically evaluate and commercialize liquid biopsy tests to detect and monitor breast cancer using its proprietary SubB2M cancer-specific probe"
That is the word I noted repeated and the path explained at the A.G.M. for the Ovarian test as well.
Ann: BARD1 Awarded BTB Funding to Develop Breast Cancer Test, page-4
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |